AU2014315422A1 - Rilyazine derivatives and compositions for the treatment of cancer - Google Patents

Rilyazine derivatives and compositions for the treatment of cancer

Info

Publication number
AU2014315422A1
AU2014315422A1 AU2014315422A AU2014315422A AU2014315422A1 AU 2014315422 A1 AU2014315422 A1 AU 2014315422A1 AU 2014315422 A AU2014315422 A AU 2014315422A AU 2014315422 A AU2014315422 A AU 2014315422A AU 2014315422 A1 AU2014315422 A1 AU 2014315422A1
Authority
AU
Australia
Prior art keywords
rilyazine
cancer
derivatives
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014315422A
Inventor
Srinivasa R. Cheruku
Thomas W. Gero
Jefferey A. Gladding
John C. Warner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Babcock Institute for Green Chemistry LLC
Original Assignee
Warner Babcock Institute for Green Chemistry LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Babcock Institute for Green Chemistry LLC filed Critical Warner Babcock Institute for Green Chemistry LLC
Publication of AU2014315422A1 publication Critical patent/AU2014315422A1/en
Abandoned legal-status Critical Current

Links

AU2014315422A 2013-09-05 2014-08-29 Rilyazine derivatives and compositions for the treatment of cancer Abandoned AU2014315422A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/874,039 2013-09-05

Publications (1)

Publication Number Publication Date
AU2014315422A1 true AU2014315422A1 (en) 2015-03-12

Family

ID=

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and compositions for the treatment of cancer
EP3060207A4 (en) Methods and compositions for treating cancer
EP3031826A4 (en) Pharmaceutical composition for treatment and/or prevention of cancer
EP3038610A4 (en) Compositions and methods for the treatment of presbyopia
EP3033079A4 (en) Methods for the treatment of her2 amplified cancer
IL238177A0 (en) Methods and compositions for the treatment of cancer
EP2967049A4 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP3004396A4 (en) Methods and compositions for the treatment of cancer
PL3089749T3 (en) Combined preparations for the treatment of cancer
EP3062790A4 (en) Pharmaceutical combinations for the treatment of cancer
EP3052102A4 (en) Compositions and methods for treating cancers
EP3008212A4 (en) Methods of treatment of cancer
EP3004395A4 (en) Compositions and methods for treating cancer
EP3003489A4 (en) Cytotoxic agents for the treatment of cancer
HK1220374A1 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP2991650A4 (en) Methods for the treatment of cancer
EP3089745A4 (en) Compounds, compositions, and methods for the treatment of cancers
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
EP3068431A4 (en) Methods and compositions for the treatment of hcmv
EP2984185A4 (en) Methods and compositions for treating cancer
EP2988737A4 (en) Methods and compositions for treating diseases
EP2994156A4 (en) Compounds, compositions and methods for the treatment of diseases through inhibiting tgf- activity
EP3049078A4 (en) Treatment of cancer
EP3016948B8 (en) 2-acylaminothiazoles for the treatment of cancer